KRAS biomarker testing disparities in colorectal cancer patients in New Mexico
Sign Up to like & getrecommendations! Published in 2017 at "Heliyon"
DOI: 10.1016/j.heliyon.2017.e00448
Abstract: Introduction American Society of Clinical Oncology (ASCO) guidelines recommend that all patients with metastatic colorectal cancer (mCRC) receive KRAS testing to guide anti-EGFR monoclonal antibody treatment. The aim of this study was to assess for… read more here.
Keywords: colorectal cancer; kras biomarker; kras testing; new mexico ... See more keywords